| Article
Conclusions from a recent cross-sectional study investigating the association between diabetes mellitus and migraine found no significant differences in the prevalence of migraine between age- and sex-matched diabetic and nondiabetic subjects, after adjusting for possible confounding variables. The...
| Article
Approximately 1 billion people in the world are affected with migraine and the thought is that about 40% of them that are candidates for some type of preventative therapy. A sizable proportion of that 40% doesn’t actually receive the kind of preventative therapy that they need, and so that equates...
| Article
Headache, by itself, is just a symptom. It’s like saying someone has arm pain; there are many causes of arm pain. There are over 300 different causes of headache; some of them are threatening, secondary headaches; some of them are not threatening but problematic--those are primary headaches. Once...
| Article
Researchers at Mayo Clinic, in collaboration with other major headache centers in the US, report favorable results from a study of single-pulse transcranial magnetic stimulation as an approach to prevention of migraine headache. In the study, entitled eNeura SpringTMS Post-Market Observational U.S....
| Article
Both the central nervous system and the peripheral nervous system are heavily involved in starting and continuing a migraine attack, and are involved before the migraine even starts. If you divide a migraine into premonitory phases–the aura, the migraine phase and then the postdrome, with modern...
| Video
Dr. Ward discusses points of differential diagnosis and strategies for treatment selection that can promote better outcomes for migraine sufferers. The Migraine Treatment Optimization Questionnaire is a tool that can help the clinician address unmet needs for their patients.
| Video
The American Headache Society's chronic Migraine Education Program (CMEP) was presented as part of the curriculum at PAINWeek 2017. In the segment, panelist Kathleen Digre, MD, discusses the interaction of central and peripheral nervous systems in triggering a migraine attack, the longer-term...
| Video
Approximately 1 billion people in the world are affected by migraine, and some 40% are estimated to be candidates for preventative therapy. Dr. Vargas outlines some objectives and principles for treating this patient population. New medications and therapies on the horizon point to better outcomes...
| Article
Survivors of a terror attack are at elevated risk for frequent migraine and tension headache, suggests the conclusions from a recent study in Norway. The investigation centered on the teenage survivors of the 2011 incident at a summer youth camp on Utoya Island in which a gunman killed 69 campers...
| Article
Results of a recent phase III clinical trial confirm the efficacy and safety of a novel antibody therapy in reducing the number of days of headache experienced by chronic migraine sufferers. The findings from the HALO CM trial, resorted by researchers from Thomas Jefferson University Hospital,...